Common Medications May Block Vitamin B1 Absorption in Small Clinical Trial

A University of California San Francisco clinical trial investigated how common medications interfere with vitamin B1 (thiamine) processing in the human body. The study specifically examined whether metformin, a widely prescribed diabetes medication, and trimethoprim, a common antibiotic, affect thiamine absorption and elimination by blocking the SLC19A3 transporter protein.

The completed trial enrolled seven participants in a two-part design spanning over four years. In Part 1, subjects received thiamine alone, thiamine with metformin, and thiamine with trimethoprim. Part 2 expanded the investigation by administering thiamine alone and thiamine with trimethoprim to measure detailed pharmacokinetic changes.

Researchers measured how these drug combinations affected the body's ability to absorb, distribute, and eliminate thiamine compared to taking the vitamin alone. This approach allowed scientists to quantify potential drug-nutrient interactions that could compromise thiamine status in patients taking these medications long-term.

While specific results weren't detailed in available summaries, this research addresses a critical gap in understanding medication-induced nutrient deficiencies. Thiamine is essential for cellular energy production, nervous system function, and cardiovascular health. Deficiency can lead to serious conditions including beriberi and neurological complications, making these interactions particularly relevant for longevity and health optimization.

The findings could inform clinical practice regarding thiamine supplementation timing and dosing for patients on metformin or trimethoprim therapy, potentially preventing deficiency-related health complications that could accelerate aging processes.